Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Examining the Dynamic Profile of Endothelin-1 Levels During Ex Vivo Lung Perfusion to Predict Post-Transplant Outcomes

FY 2023-24

Summary
Lung transplantation is the primary intervention for end-stage lung diseases. However, limited donor organs are accepted for transplant due to concerns of poor patient outcomes. The ex vivo lung perfusion (EVLP) system was developed to extend the donor assessment period by mimicking the lung's physiological conditions via mechanical ventilation and perfusate circulation. EVLP allows for a comprehensive assessment of biological, physiological, and biochemical measures to evaluate marginal lungs. Yet, following EVLP many lungs still get rejected for transplant due to concerns of poor recipient outcomes. Levels of various biomarkers have been tested in EVLP perfusate and show potential usefulness in determining organ suitability. Endothelin-1 (ET-1), a vasoconstrictive chemokine, is proposed to be a biomarker that determines endothelial function. Our initial findings show a unique fluctuating profile of ET-1, not seen in other biomarkers. Yet, this profile has not been examined with respect to ET-1 gene expression and lung injury. We hypothesize that ET-1 plays an essential role in the endothelial function of human lungs and may influence post-transplant outcomes. To test this, we will use perfusate samples collected from EVLP cases and measure ET-1 protein levels. We will analyze ET-1 gene pathways via bioinformatics. These levels will be assessed in relation to donor characteristics and recipient clinical outcomes. These results will provide valuable information to clinicians regarding the endothelial function of the donor lung to make informed decisions regarding transplant suitability, increasing the number of healthy donor lungs utilized. The molecular mechanisms discovered in this study will help identify potential therapeutic targets for donor lung repair.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506424
Name
McCaig Abby
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Examining the Dynamic Profile of Endothelin-1 Levels During Ex Vivo Lung Perfusion to Predict Post-Transplant Outcomes
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarker Discovery; Endothelin-1; Ex Vivo Lung Perfusion; Lung Transplant; Patient Outcomes; Perfusate; Thoracic Surgery
Abstract
Lung transplantation is the primary intervention for end-stage lung diseases. However, limited donor organs are accepted for transplant due to concerns of poor patient outcomes. The ex vivo lung perfusion (EVLP) system was developed to extend the donor assessment period by mimicking the lung's physiological conditions via mechanical ventilation and perfusate circulation. EVLP allows for a comprehensive assessment of biological, physiological, and biochemical measures to evaluate marginal lungs. Yet, following EVLP many lungs still get rejected for transplant due to concerns of poor recipient outcomes. Levels of various biomarkers have been tested in EVLP perfusate and show potential usefulness in determining organ suitability. Endothelin-1 (ET-1), a vasoconstrictive chemokine, is proposed to be a biomarker that determines endothelial function. Our initial findings show a unique fluctuating profile of ET-1, not seen in other biomarkers. Yet, this profile has not been examined with respect to ET-1 gene expression and lung injury. We hypothesize that ET-1 plays an essential role in the endothelial function of human lungs and may influence post-transplant outcomes. To test this, we will use perfusate samples collected from EVLP cases and measure ET-1 protein levels. We will analyze ET-1 gene pathways via bioinformatics. These levels will be assessed in relation to donor characteristics and recipient clinical outcomes. These results will provide valuable information to clinicians regarding the endothelial function of the donor lung to make informed decisions regarding transplant suitability, increasing the number of healthy donor lungs utilized. The molecular mechanisms discovered in this study will help identify potential therapeutic targets for donor lung repair.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
McCaig, Abby
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~